Total Payments
$42,351
2024 Payments
$644.73
Companies
9
Transactions
138
Medicare Patients
2,118
Medicare Billing
$582,995
Payment Breakdown by Category
Other$37,510 (88.6%)
Food & Beverage$2,650 (6.3%)
Travel$2,191 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,510 | 26 | 88.6% |
| Food and Beverage | $2,650 | 105 | 6.3% |
| Travel and Lodging | $2,191 | 7 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $29,832 | 46 | $0 (2022) |
| ABBVIE INC. | $12,299 | 79 | $0 (2024) |
| Pernix Therapeutics Holdings, Inc. | $61.48 | 4 | $0 (2017) |
| SCILEX PHARMACEUTICALS INC. | $40.65 | 2 | $0 (2024) |
| PFIZER INC. | $40.10 | 2 | $0 (2024) |
| Lilly USA, LLC | $23.20 | 2 | $0 (2022) |
| Eisai Inc. | $21.12 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $19.37 | 1 | $0 (2024) |
| Amgen Inc. | $14.59 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $644.73 | 30 | ABBVIE INC. ($523.49) |
| 2023 | $501.05 | 29 | ABBVIE INC. ($501.05) |
| 2022 | $10,342 | 31 | ABBVIE INC. ($6,644) |
| 2021 | $22,483 | 25 | Allergan, Inc. ($17,842) |
| 2020 | $8,319 | 19 | Allergan, Inc. ($8,319) |
| 2017 | $61.48 | 4 | Pernix Therapeutics Holdings, Inc. ($61.48) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: PAIN | ||||||
| 11/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Neurology | ||||||
| 09/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Analgesic | ||||||
| 06/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Analgesic | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PAIN | ||||||
| 04/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: NEUROSCIENCE | ||||||
| 04/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 503 | 16,268 | $550,448 | $142,030 |
| 2022 | 12 | 536 | 18,667 | $611,267 | $159,418 |
| 2021 | 13 | 564 | 15,885 | $528,477 | $138,649 |
| 2020 | 13 | 515 | 19,143 | $573,708 | $142,898 |
Total Patients
2,118
Total Services
69,963
Medicare Billing
$582,995
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 31 | 15,606 | $233,883 | $76,463 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 230 | $103,500 | $17,648 | 17.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 30 | 83 | $35,275 | $13,214 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $42,500 | $11,607 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 76 | $38,000 | $8,630 | 22.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 33 | 68 | $68,000 | $6,187 | 9.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 27 | 28 | $19,600 | $5,480 | 28.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 20 | 34 | $5,950 | $1,978 | 33.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 14 | 15 | $2,850 | $822.22 | 28.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 19 | 20 | $200.00 | $1.90 | 1.0% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2023 | 22 | 23 | $690.00 | $0.44 | 0.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 35 | 17,985 | $269,712 | $86,917 | 32.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 34 | 93 | $39,525 | $15,985 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 178 | $80,100 | $14,349 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 90 | 90 | $45,000 | $13,836 | 30.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 51 | 101 | $101,000 | $9,557 | 9.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 37 | 37 | $25,900 | $7,767 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 47 | $23,500 | $5,217 | 22.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 13 | 13 | $7,800 | $2,280 | 29.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 35 | 38 | $13,300 | $2,126 | 16.0% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 21 | 22 | $4,180 | $1,380 | 33.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 25 | 32 | $320.00 | $3.04 | 1.0% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2022 | 28 | 31 | $930.00 | $0.62 | 0.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 32 | 15,113 | $226,667 | $72,395 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 121 | 174 | $78,300 | $14,600 | 18.6% |
About Dr. Alla Mesh, MD
Dr. Alla Mesh, MD is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174731426.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alla Mesh, MD has received a total of $42,351 in payments from pharmaceutical and medical device companies, with $644.73 received in 2024. These payments were reported across 138 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,510).
As a Medicare-enrolled provider, Mesh has provided services to 2,118 Medicare beneficiaries, totaling 69,963 services with total Medicare billing of $582,995. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Brooklyn, NY
- Active Since 05/18/2007
- Last Updated 07/30/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174731426
Products in Payments
- BOTOX (Biological) $28,800
- UBRELVY (Drug) $13,041
- QULIPTA (Drug) $289.73
- TREXIMET (Drug) $61.48
- ZTLido (Drug) $40.65
- NURTEC ODT (Drug) $40.10
- EMGALITY (Drug) $23.20
- Leqembi (Drug) $21.12
- Austedo XR (Drug) $19.37
- Aimovig (Biological) $14.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Neurology $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Neurology $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Neurology $126,065
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Neurology $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Neurology $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680
Neurology $96,680